Your browser doesn't support javascript.
loading
Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy.
Stoddard, Madison; Yuan, Lin; Sarkar, Sharanya; Mangalaganesh, Shruthi; Nolan, Ryan P; Bottino, Dean; Hather, Greg; Hochberg, Natasha S; White, Laura F; Chakravarty, Arijit.
Affiliation
  • Stoddard M; Fractal Therapeutics, Lexington, MA 02420, USA.
  • Yuan L; Fractal Therapeutics, Lexington, MA 02420, USA.
  • Sarkar S; Department of Microbiology and Immunology, Dartmouth College, Hanover, NH 03755, USA.
  • Mangalaganesh S; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC 3800, Australia.
  • Nolan RP; Halozyme Therapeutics, San Diego, CA 92130, USA.
  • Bottino D; Takeda Pharmaceuticals, Cambridge, MA 02139, USA.
  • Hather G; Sage Therapeutics, Cambridge, MA 02142, USA.
  • Hochberg NS; Department of Epidemiology, Boston University School of Public Health, Boston, MA 02215, USA.
  • White LF; Department of Medicine, Boston University School of Medicine, Boston, MA 02215, USA.
  • Chakravarty A; Boston Medical Center, Boston, MA 02118, USA.
Vaccines (Basel) ; 11(4)2023 Apr 06.
Article de En | MEDLINE | ID: mdl-37112718

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Vaccines (Basel) Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Vaccines (Basel) Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique